William Leland Edwards‘ fund, Palo Alto Investors, just reported cutting down its entire position in nano-cap company Savient Pharmaceuticals Inc (OTCMKTS:SVNTQ). In its latest 13F, Palo Alto revealed holding over 9.74 million shares of Savient.
Recommended Reading:
Phil Frohlich, Prescott Still Loading Up on China Marine Food Group
Hillhouse Capital Management Discloses New Stake in Qunar Cayman Islands
Noam Gottesman, GLG Partners Are Bullish on Tableau Software
